Quality assured preclinical & clinical testing solutions

Preclinical and Clinical Testing

TetraQ provides contract preclinical and clinical testing services to biopharmaceutical companies that are engaged in the business of developing new pharmaceuticals for human use and who are seeking assistance with selecting or confirming a drug candidate - see Roadmap.

Accreditation
TetraQ is GLP-recognized for its bioanalytical and toxicology services thereby ensuring that the data generated will be accepted for review by the international regulatory agencies such as the FDA, EMA and TGA.

Scope
TetraQ regularly provides GLP bioanalytical services to support preclinical studies as well as early phase clinical trials and bioequivalence studies in humans.

Trouble-shooting
TetraQ has a track record in trouble-shooting difficulties in developing bioanalytical methods to detect and measure compounds and has an extensive library of fully validated bioanalytical methods on file.

Advice
Preclinical and Clinical studies vary widely in complexity, costs, duration and importance. Careful planning in the early stages of a project can minimise costs and maximise results. TetraQ can assist to optimize preclinical and clinical drug development plans.

Fact Sheets

TetraQ Capabilities

Overview of Capabilities and Services

More...
All Factsheets

Our Partners

Useful Links

Technical infrastructure

Information about the laboratories and technical infrastructure More...

Quality System

TetraQ operates within a quality framework in compliance with international standards More...

More...

Fact Sheets

TetraQ Capabilities

Overview of Capabilities and Services

More...
All Factsheets